[HTML][HTML] Measurements of medial temporal lobe atrophy for prediction of Alzheimer's disease in subjects with mild cognitive impairment
L Clerx, IA van Rossum, L Burns, DL Knol… - Neurobiology of …, 2013 - Elsevier
Our aim was to compare the predictive accuracy of 4 different medial temporal lobe
measurements for Alzheimer's disease (AD) in subjects with mild cognitive impairment …
measurements for Alzheimer's disease (AD) in subjects with mild cognitive impairment …
Medial temporal lobe atrophy predicts Alzheimer's disease in patients with minor cognitive impairment
PJ Visser, FRJ Verhey, PAM Hofman… - Journal of Neurology …, 2002 - jnnp.bmj.com
Objectives: To investigate whether medial temporal lobe atrophy predicted outcome in
patients with minor cognitive impairment and whether assessment of the medial temporal …
patients with minor cognitive impairment and whether assessment of the medial temporal …
Practical use of visual medial temporal lobe atrophy cut-off scores in Alzheimer's disease: validation in a large memory clinic population
JJ Claus, SS Staekenborg, DC Holl, JJ Roorda… - European …, 2017 - Springer
Objective To provide age-specific medial temporal lobe atrophy (MTA) cut-off scores for
routine clinical practice as marker for Alzheimer's disease (AD). Methods Patients with AD …
routine clinical practice as marker for Alzheimer's disease (AD). Methods Patients with AD …
High-throughput, fully automated volumetry for prediction of MMSE and CDR decline in mild cognitive impairment
Medial temporal lobe (MTL) atrophy is associated with increased risk for conversion to
Alzheimer disease, but manual tracing techniques and even semiautomated techniques for …
Alzheimer disease, but manual tracing techniques and even semiautomated techniques for …
Application of automated medial temporal lobe atrophy scale to Alzheimer disease
BH Ridha, J Barnes, LA Van De Pol… - Archives of …, 2007 - jamanetwork.com
Objective To compare an automated intensity-based measure of medial temporal atrophy in
Alzheimer disease (AD) with existing volumetric and visually based methods. Design …
Alzheimer disease (AD) with existing volumetric and visually based methods. Design …
[HTML][HTML] Progressive medial temporal lobe atrophy during preclinical Alzheimer's disease
This study examined whether longitudinal MRI trajectories in medial temporal lobe (MTL)
brain regions differed among groups of cognitively normal individuals defined by their …
brain regions differed among groups of cognitively normal individuals defined by their …
Medial temporal lobe atrophy and memory dysfunction as predictors for dementia in subjects with mild cognitive impairment
To determine whether the medial temporal lobe is atrophic in subjects with mild cognitive
impairment, and whether atrophy of this structure is a better predictor of dementia than …
impairment, and whether atrophy of this structure is a better predictor of dementia than …
Validity and reliability of the medial temporal lobe atrophy scale in a memory clinic population
A Molinder, D Ziegelitz, SE Maier, C Eckerström - BMC neurology, 2021 - Springer
Background Visual rating of medial temporal lobe atrophy (MTA) is often performed in
conjunction with dementia workup. Most prior studies involved patients with known or …
conjunction with dementia workup. Most prior studies involved patients with known or …
Hippocampal atrophy rates in Alzheimer disease: added value over whole brain volume measures
WJP Henneman, JD Sluimer, J Barnes… - Neurology, 2009 - AAN Enterprises
Objective: To investigate the added value of hippocampal atrophy rates over whole brain
volume measurements on MRI in patients with Alzheimer disease (AD), patients with mild …
volume measurements on MRI in patients with Alzheimer disease (AD), patients with mild …
The utility of age-specific cut-offs for visual rating of medial temporal atrophy in classifying Alzheimer's disease, MCI and cognitively normal elderly subjects
R Duara, DA Loewenstein, Q Shen… - Frontiers in aging …, 2013 - frontiersin.org
Background: New research criteria for diagnosing Alzheimer's disease (AD) in the mild
cognitive impairment stage (MCI-AD) incorporate biomarkers to assign a level of certainty to …
cognitive impairment stage (MCI-AD) incorporate biomarkers to assign a level of certainty to …
相关搜索
- alzheimer's disease lobe atrophy
- dementia in subjects lobe atrophy
- alzheimer disease brain volume measures
- alzheimer's disease elderly subjects
- alzheimer's disease visual rating
- phosphorylated tau lobe atrophy
- csf aβ42 lobe atrophy
- alzheimer's disease cut offs
- alzheimer's disease practical use
- atrophy rates brain volume measures
- memory dysfunction lobe atrophy
- practical use lobe atrophy
- alzheimer disease atrophy rates
- predictors for dementia lobe atrophy